The stock of Personalis Inc (PSNL) has seen a -0.88% decrease in the past week, with a 64.06% gain in the past month, and a 332.06% flourish in the past quarter. The volatility ratio for the week is 10.56%, and the volatility levels for the past 30 days are at 18.22% for PSNL. The simple moving average for the past 20 days is 20.14% for PSNL’s stock, with a 201.72% simple moving average for the past 200 days.
Is It Worth Investing in Personalis Inc (NASDAQ: PSNL) Right Now?
PSNL has 36-month beta value of 1.88. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for PSNL is 31.14M, and currently, short sellers hold a 6.36% ratio of that float. The average trading volume of PSNL on August 29, 2024 was 1.28M shares.
PSNL) stock’s latest price update
Personalis Inc (NASDAQ: PSNL) has seen a rise in its stock price by 2.35 in relation to its previous close of 5.53. However, the company has experienced a -0.88% decline in its stock price over the last five trading sessions. businesswire.com reported 2024-08-22 that FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will participate at the following investor conferences: Morgan Stanley 22nd Annual Global Healthcare Conference Date: Thursday, September 5, 2024 Presentation Time: 4:50 pm Eastern Time Location: Marriott Marquis in New York Lake Street 8th Annual Best Ideas Growth (BIG) Conference Date: Thursday, September 12, 2024 Location: Yale Club.
Analysts’ Opinion of PSNL
Many brokerage firms have already submitted their reports for PSNL stocks, with Needham repeating the rating for PSNL by listing it as a “Buy.” The predicted price for PSNL in the upcoming period, according to Needham is $8 based on the research report published on February 06, 2023 of the previous year 2023.
BofA Securities gave a rating of “Buy” to PSNL, setting the target price at $23 in the report published on January 07th of the previous year.
PSNL Trading at 84.11% from the 50-Day Moving Average
After a stumble in the market that brought PSNL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.39% of loss for the given period.
Volatility was left at 18.22%, however, over the last 30 days, the volatility rate increased by 10.56%, as shares surge +60.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +353.97% upper at present.
During the last 5 trading sessions, PSNL rose by +0.18%, which changed the moving average for the period of 200-days by +460.78% in comparison to the 20-day moving average, which settled at $4.82. In addition, Personalis Inc saw 169.52% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PSNL starting from Tempus AI, Inc., who purchase 3,500,000 shares at the price of $5.07 back on Aug 16 ’24. After this action, Tempus AI, Inc. now owns 12,718,800 shares of Personalis Inc, valued at $17,745,000 using the latest closing price.
Chen Richard, the CHIEF MEDICAL OFFICER AND EVP of Personalis Inc, sale 524 shares at $2.97 during a trade that took place back on Jul 30 ’24, which means that Chen Richard is holding 127,227 shares at $1,556 based on the most recent closing price.
Stock Fundamentals for PSNL
Current profitability levels for the company are sitting at:
- -1.08 for the present operating margin
- 0.28 for the gross margin
The net margin for Personalis Inc stands at -1.02. The total capital return value is set at -0.57. Equity return is now at value -56.49, with -37.49 for asset returns.
Based on Personalis Inc (PSNL), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -6.04. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is -3604.08.
Currently, EBITDA for the company is -85.0 million with net debt to EBITDA at 0.02. When we switch over and look at the enterprise to sales, we see a ratio of 3.7. The receivables turnover for the company is 6.19for trailing twelve months and the total asset turnover is 0.43. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.18.
Conclusion
To put it simply, Personalis Inc (PSNL) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
